| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 78 | 2024 | 4712 | 4.300 |
Why?
|
| Catheter Ablation | 66 | 2024 | 2780 | 3.840 |
Why?
|
| Tachycardia, Supraventricular | 21 | 2023 | 273 | 3.220 |
Why?
|
| Wolff-Parkinson-White Syndrome | 13 | 2023 | 117 | 3.110 |
Why?
|
| Heart Conduction System | 29 | 2021 | 1009 | 3.030 |
Why?
|
| Arrhythmias, Cardiac | 32 | 2023 | 2258 | 2.750 |
Why?
|
| Long QT Syndrome | 12 | 2017 | 472 | 2.590 |
Why?
|
| Electrocardiography | 52 | 2024 | 6412 | 2.560 |
Why?
|
| Defibrillators, Implantable | 34 | 2023 | 1498 | 2.350 |
Why?
|
| Death, Sudden, Cardiac | 18 | 2023 | 1567 | 2.100 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 16 | 2024 | 148 | 1.920 |
Why?
|
| Tachycardia, Ventricular | 21 | 2023 | 1309 | 1.780 |
Why?
|
| Fontan Procedure | 13 | 2018 | 805 | 1.710 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 19 | 2024 | 511 | 1.680 |
Why?
|
| Accessory Atrioventricular Bundle | 6 | 2021 | 58 | 1.680 |
Why?
|
| Body Surface Potential Mapping | 11 | 2024 | 228 | 1.420 |
Why?
|
| Tachycardia, Ectopic Atrial | 6 | 2011 | 65 | 1.250 |
Why?
|
| Neonatal Screening | 5 | 2015 | 620 | 1.240 |
Why?
|
| Cardiac Pacing, Artificial | 21 | 2014 | 881 | 1.190 |
Why?
|
| Tetralogy of Fallot | 7 | 2024 | 628 | 1.120 |
Why?
|
| Heart Block | 10 | 2022 | 390 | 1.020 |
Why?
|
| Electric Countershock | 15 | 2023 | 534 | 0.980 |
Why?
|
| Models, Cardiovascular | 11 | 2009 | 981 | 0.980 |
Why?
|
| Cardiac Electrophysiology | 5 | 2021 | 60 | 0.980 |
Why?
|
| Tachycardia | 11 | 2023 | 599 | 0.910 |
Why?
|
| Pacemaker, Artificial | 16 | 2022 | 828 | 0.810 |
Why?
|
| Pre-Excitation Syndromes | 2 | 2021 | 27 | 0.800 |
Why?
|
| Electrophysiology | 8 | 2022 | 1266 | 0.790 |
Why?
|
| Atrial Flutter | 8 | 2023 | 253 | 0.770 |
Why?
|
| Child | 112 | 2024 | 80917 | 0.740 |
Why?
|
| Atrial Fibrillation | 12 | 2023 | 5176 | 0.730 |
Why?
|
| Heart Atria | 14 | 2013 | 1361 | 0.710 |
Why?
|
| Heart Rate | 18 | 2020 | 4214 | 0.700 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2024 | 2145 | 0.680 |
Why?
|
| Cardiac Surgical Procedures | 15 | 2024 | 3683 | 0.680 |
Why?
|
| Bundle-Branch Block | 3 | 2018 | 278 | 0.630 |
Why?
|
| Finite Element Analysis | 3 | 2010 | 441 | 0.600 |
Why?
|
| Echocardiography | 13 | 2024 | 5047 | 0.590 |
Why?
|
| Child, Preschool | 72 | 2024 | 42669 | 0.590 |
Why?
|
| Ventricular Fibrillation | 5 | 2018 | 537 | 0.550 |
Why?
|
| Adolescent | 93 | 2024 | 89169 | 0.520 |
Why?
|
| Heart Ventricles | 7 | 2024 | 3841 | 0.520 |
Why?
|
| Tachycardia, Sinoatrial Nodal Reentry | 4 | 2004 | 8 | 0.510 |
Why?
|
| Electrodes, Implanted | 9 | 2010 | 836 | 0.480 |
Why?
|
| Radiography, Interventional | 3 | 2013 | 1131 | 0.480 |
Why?
|
| Ebstein Anomaly | 3 | 2023 | 106 | 0.480 |
Why?
|
| Atrioventricular Block | 3 | 2024 | 141 | 0.470 |
Why?
|
| Cardiology | 6 | 2021 | 1702 | 0.470 |
Why?
|
| Vectorcardiography | 2 | 2005 | 48 | 0.470 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2013 | 72 | 0.450 |
Why?
|
| Isoproterenol | 1 | 2014 | 398 | 0.440 |
Why?
|
| Humans | 196 | 2024 | 768166 | 0.440 |
Why?
|
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2013 | 63 | 0.440 |
Why?
|
| Thorax | 1 | 2016 | 557 | 0.430 |
Why?
|
| Radiation Dosage | 2 | 2013 | 1967 | 0.430 |
Why?
|
| Monitoring, Physiologic | 3 | 2018 | 1798 | 0.420 |
Why?
|
| Electrodes | 4 | 2018 | 617 | 0.420 |
Why?
|
| Sick Sinus Syndrome | 2 | 2012 | 51 | 0.420 |
Why?
|
| Infant | 53 | 2024 | 36535 | 0.420 |
Why?
|
| Heart Septum | 5 | 2019 | 304 | 0.410 |
Why?
|
| International Cooperation | 2 | 2016 | 1436 | 0.410 |
Why?
|
| Regenerative Medicine | 1 | 2016 | 313 | 0.410 |
Why?
|
| Electrocardiography, Ambulatory | 6 | 2020 | 582 | 0.410 |
Why?
|
| Fluoroscopy | 4 | 2013 | 947 | 0.400 |
Why?
|
| Tachycardia, Reciprocating | 1 | 2012 | 15 | 0.400 |
Why?
|
| Transposition of Great Vessels | 3 | 2023 | 580 | 0.390 |
Why?
|
| Ablation Techniques | 1 | 2014 | 255 | 0.380 |
Why?
|
| Therapy, Computer-Assisted | 3 | 2008 | 265 | 0.380 |
Why?
|
| Pediatrics | 4 | 2016 | 3629 | 0.370 |
Why?
|
| Computer Simulation | 11 | 2018 | 6283 | 0.370 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3929 | 0.360 |
Why?
|
| Treatment Outcome | 55 | 2023 | 65371 | 0.350 |
Why?
|
| Risk Assessment | 17 | 2021 | 24315 | 0.340 |
Why?
|
| Tachycardia, Ectopic Junctional | 5 | 2023 | 20 | 0.340 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2005 | 709 | 0.330 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 620 | 0.330 |
Why?
|
| Retrospective Studies | 59 | 2024 | 81762 | 0.320 |
Why?
|
| Cryosurgery | 3 | 2009 | 479 | 0.310 |
Why?
|
| Troponin T | 1 | 2013 | 787 | 0.310 |
Why?
|
| Brugada Syndrome | 1 | 2009 | 98 | 0.300 |
Why?
|
| Boston | 10 | 2018 | 9374 | 0.300 |
Why?
|
| Genetic Markers | 1 | 2014 | 2603 | 0.300 |
Why?
|
| Adrenergic Agonists | 1 | 2008 | 57 | 0.300 |
Why?
|
| Anti-Arrhythmia Agents | 10 | 2023 | 775 | 0.290 |
Why?
|
| Postoperative Complications | 15 | 2024 | 15832 | 0.290 |
Why?
|
| Disease Management | 2 | 2016 | 2536 | 0.290 |
Why?
|
| Societies, Medical | 3 | 2016 | 3968 | 0.290 |
Why?
|
| Heart | 8 | 2022 | 4446 | 0.290 |
Why?
|
| Atrioventricular Node | 7 | 2016 | 180 | 0.280 |
Why?
|
| Female | 103 | 2024 | 397192 | 0.280 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2013 | 1003 | 0.280 |
Why?
|
| Male | 99 | 2024 | 364719 | 0.280 |
Why?
|
| Age Factors | 14 | 2018 | 18412 | 0.270 |
Why?
|
| Radiation Protection | 1 | 2010 | 428 | 0.270 |
Why?
|
| Endosonography | 1 | 2010 | 626 | 0.270 |
Why?
|
| Adult | 76 | 2024 | 223646 | 0.260 |
Why?
|
| Prosthesis Implantation | 3 | 2010 | 594 | 0.260 |
Why?
|
| Heart Diseases | 7 | 2012 | 2819 | 0.250 |
Why?
|
| Neural Conduction | 2 | 2004 | 443 | 0.240 |
Why?
|
| Registries | 6 | 2016 | 8375 | 0.240 |
Why?
|
| Young Adult | 29 | 2024 | 60066 | 0.230 |
Why?
|
| Epinephrine | 1 | 2008 | 794 | 0.230 |
Why?
|
| Follow-Up Studies | 29 | 2020 | 39348 | 0.230 |
Why?
|
| Mutation, Missense | 1 | 2013 | 2592 | 0.230 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 1168 | 0.220 |
Why?
|
| Radiation Injuries | 1 | 2010 | 1198 | 0.210 |
Why?
|
| Intracranial Thrombosis | 1 | 2004 | 109 | 0.210 |
Why?
|
| Cardiac Resynchronization Therapy | 4 | 2018 | 560 | 0.210 |
Why?
|
| Models, Statistical | 4 | 2015 | 5107 | 0.210 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2022 | 60 | 0.210 |
Why?
|
| Intracranial Embolism | 1 | 2004 | 188 | 0.200 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 2 | 2021 | 153 | 0.200 |
Why?
|
| Sensitivity and Specificity | 10 | 2014 | 14729 | 0.200 |
Why?
|
| United States Food and Drug Administration | 2 | 2022 | 1673 | 0.200 |
Why?
|
| Risk Factors | 28 | 2020 | 74944 | 0.200 |
Why?
|
| Infant, Newborn | 24 | 2020 | 26422 | 0.200 |
Why?
|
| Hypotension | 1 | 2008 | 888 | 0.190 |
Why?
|
| Athletic Injuries | 1 | 2012 | 1245 | 0.190 |
Why?
|
| Punctures | 2 | 2013 | 372 | 0.190 |
Why?
|
| Myocardium | 3 | 2012 | 4788 | 0.190 |
Why?
|
| Forecasting | 5 | 2019 | 2945 | 0.180 |
Why?
|
| Prostheses and Implants | 5 | 2019 | 1276 | 0.180 |
Why?
|
| Prevalence | 12 | 2020 | 15869 | 0.180 |
Why?
|
| Thromboembolism | 3 | 2017 | 1004 | 0.180 |
Why?
|
| Biomedical Research | 1 | 2016 | 3463 | 0.180 |
Why?
|
| DNA | 1 | 2014 | 7214 | 0.180 |
Why?
|
| Genetic Testing | 1 | 2013 | 3591 | 0.170 |
Why?
|
| Sotalol | 1 | 2020 | 47 | 0.170 |
Why?
|
| Food Hypersensitivity | 1 | 2008 | 734 | 0.170 |
Why?
|
| Electronics | 4 | 2021 | 317 | 0.170 |
Why?
|
| Autonomic Nervous System | 4 | 2001 | 707 | 0.160 |
Why?
|
| Mass Screening | 2 | 2012 | 5458 | 0.160 |
Why?
|
| Perfusion | 1 | 2004 | 1401 | 0.160 |
Why?
|
| Endocardium | 2 | 1997 | 249 | 0.160 |
Why?
|
| American Heart Association | 4 | 2021 | 1050 | 0.160 |
Why?
|
| Chi-Square Distribution | 4 | 2012 | 3436 | 0.160 |
Why?
|
| Quality Improvement | 2 | 2015 | 3857 | 0.150 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2016 | 1243 | 0.150 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2024 | 856 | 0.150 |
Why?
|
| Respiration | 3 | 1997 | 1665 | 0.150 |
Why?
|
| Equipment Failure | 8 | 2014 | 585 | 0.150 |
Why?
|
| Signal Processing, Computer-Assisted | 6 | 2008 | 1489 | 0.140 |
Why?
|
| Time Factors | 14 | 2020 | 40218 | 0.140 |
Why?
|
| User-Computer Interface | 1 | 2004 | 1407 | 0.140 |
Why?
|
| Survival Rate | 10 | 2016 | 12840 | 0.140 |
Why?
|
| Recurrence | 12 | 2022 | 8509 | 0.140 |
Why?
|
| Blood Volume | 2 | 2002 | 545 | 0.140 |
Why?
|
| Incidence | 10 | 2020 | 21538 | 0.140 |
Why?
|
| Equipment Design | 9 | 2018 | 3522 | 0.140 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 1171 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 5 | 2012 | 5536 | 0.140 |
Why?
|
| Device Approval | 1 | 2018 | 164 | 0.140 |
Why?
|
| Stroke Volume | 2 | 2024 | 5622 | 0.140 |
Why?
|
| Blood Pressure | 7 | 2005 | 8543 | 0.140 |
Why?
|
| Aortic Coarctation | 1 | 2018 | 278 | 0.130 |
Why?
|
| Baroreflex | 4 | 2002 | 154 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2007 | 4063 | 0.130 |
Why?
|
| Multivariate Analysis | 5 | 2014 | 12077 | 0.130 |
Why?
|
| Decision Making | 2 | 2014 | 3953 | 0.130 |
Why?
|
| Sudden Infant Death | 2 | 2014 | 293 | 0.130 |
Why?
|
| United States | 16 | 2022 | 73039 | 0.130 |
Why?
|
| Device Removal | 3 | 2022 | 643 | 0.130 |
Why?
|
| Ultrasonography, Interventional | 4 | 2013 | 1523 | 0.130 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2017 | 345 | 0.130 |
Why?
|
| Central Venous Pressure | 2 | 2002 | 80 | 0.130 |
Why?
|
| Arrhythmia, Sinus | 1 | 1995 | 48 | 0.130 |
Why?
|
| Canada | 3 | 2016 | 2130 | 0.120 |
Why?
|
| Predictive Value of Tests | 6 | 2024 | 15454 | 0.120 |
Why?
|
| Consensus | 4 | 2021 | 3212 | 0.120 |
Why?
|
| Heart Bypass, Right | 1 | 2015 | 75 | 0.120 |
Why?
|
| Telemetry | 3 | 2020 | 200 | 0.120 |
Why?
|
| Norwood Procedures | 1 | 2016 | 192 | 0.120 |
Why?
|
| Psychometrics | 1 | 2004 | 3063 | 0.120 |
Why?
|
| Algorithms | 7 | 2018 | 14164 | 0.110 |
Why?
|
| Tendons | 1 | 2018 | 556 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2000 | 843 | 0.110 |
Why?
|
| Pediatric Assistants | 1 | 2013 | 8 | 0.110 |
Why?
|
| Logistic Models | 4 | 2014 | 13290 | 0.110 |
Why?
|
| Hospital Charges | 1 | 2015 | 347 | 0.100 |
Why?
|
| Pericardium | 1 | 2017 | 679 | 0.100 |
Why?
|
| Sheep | 2 | 2010 | 1451 | 0.100 |
Why?
|
| Middle Aged | 32 | 2024 | 223492 | 0.100 |
Why?
|
| Hospital Costs | 1 | 2018 | 957 | 0.100 |
Why?
|
| Vena Cava, Superior | 1 | 1993 | 197 | 0.100 |
Why?
|
| Collateral Circulation | 1 | 1993 | 291 | 0.100 |
Why?
|
| False Positive Reactions | 1 | 2014 | 963 | 0.100 |
Why?
|
| Reproducibility of Results | 7 | 2018 | 20227 | 0.100 |
Why?
|
| Reflex | 1 | 1994 | 375 | 0.100 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2012 | 139 | 0.100 |
Why?
|
| Swine | 8 | 2007 | 5995 | 0.100 |
Why?
|
| Differential Threshold | 2 | 2012 | 80 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 724 | 0.090 |
Why?
|
| Feasibility Studies | 7 | 2017 | 5315 | 0.090 |
Why?
|
| Sports | 1 | 2017 | 703 | 0.090 |
Why?
|
| Survival Analysis | 7 | 2009 | 10101 | 0.090 |
Why?
|
| Prospective Studies | 10 | 2015 | 54926 | 0.090 |
Why?
|
| Syncope | 2 | 2019 | 430 | 0.090 |
Why?
|
| Body Size | 3 | 2010 | 463 | 0.090 |
Why?
|
| Heart Septal Defects | 1 | 1992 | 191 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2016 | 812 | 0.090 |
Why?
|
| Respiration Disorders | 1 | 2014 | 364 | 0.090 |
Why?
|
| Spirometry | 1 | 2014 | 929 | 0.090 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2013 | 477 | 0.090 |
Why?
|
| Amiodarone | 2 | 2005 | 217 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2016 | 1141 | 0.080 |
Why?
|
| Equipment Failure Analysis | 2 | 2009 | 845 | 0.080 |
Why?
|
| Autopsy | 1 | 2013 | 1011 | 0.080 |
Why?
|
| Radiation, Ionizing | 1 | 2010 | 252 | 0.080 |
Why?
|
| Mutation | 1 | 2014 | 30238 | 0.080 |
Why?
|
| Secondary Prevention | 1 | 2016 | 1474 | 0.080 |
Why?
|
| Bundle of His | 2 | 2024 | 102 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2665 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2013 | 1836 | 0.080 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2004 | 615 | 0.080 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 2055 | 0.080 |
Why?
|
| Regression Analysis | 4 | 2010 | 6340 | 0.080 |
Why?
|
| Models, Anatomic | 2 | 2010 | 680 | 0.080 |
Why?
|
| Biomedical Technology | 1 | 2010 | 210 | 0.080 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 2430 | 0.070 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2005 | 452 | 0.070 |
Why?
|
| Thrombosis | 2 | 2020 | 2957 | 0.070 |
Why?
|
| Heart Neoplasms | 1 | 2011 | 374 | 0.070 |
Why?
|
| Catheters, Indwelling | 2 | 2003 | 436 | 0.070 |
Why?
|
| Cold Temperature | 2 | 2005 | 791 | 0.070 |
Why?
|
| Surgical Instruments | 2 | 2007 | 381 | 0.070 |
Why?
|
| Sinoatrial Node | 2 | 2001 | 99 | 0.070 |
Why?
|
| Cardiovascular Agents | 1 | 2013 | 849 | 0.070 |
Why?
|
| Primary Prevention | 1 | 2014 | 1188 | 0.070 |
Why?
|
| Atrial Appendage | 1 | 2010 | 285 | 0.070 |
Why?
|
| Benchmarking | 1 | 2013 | 1057 | 0.070 |
Why?
|
| Electromagnetic Fields | 1 | 2008 | 289 | 0.070 |
Why?
|
| Exercise Test | 1 | 2014 | 2186 | 0.070 |
Why?
|
| Coronary Vessels | 3 | 2006 | 3124 | 0.070 |
Why?
|
| Computers, Handheld | 1 | 2008 | 211 | 0.060 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 1424 | 0.060 |
Why?
|
| Pedigree | 1 | 2013 | 4539 | 0.060 |
Why?
|
| Tumor Stem Cell Assay | 1 | 1985 | 116 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2012 | 3729 | 0.060 |
Why?
|
| Survivors | 1 | 2016 | 2381 | 0.060 |
Why?
|
| Cor Triatriatum | 1 | 2005 | 14 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2006 | 195 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 1993 | 1408 | 0.060 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2012 | 1334 | 0.060 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2012 | 1741 | 0.060 |
Why?
|
| Colony-Forming Units Assay | 1 | 1985 | 351 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2011 | 9015 | 0.060 |
Why?
|
| Comorbidity | 4 | 2014 | 10590 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2010 | 18349 | 0.060 |
Why?
|
| Warfarin | 1 | 2013 | 1493 | 0.060 |
Why?
|
| Control Groups | 1 | 2005 | 107 | 0.060 |
Why?
|
| Tricuspid Atresia | 1 | 2004 | 37 | 0.060 |
Why?
|
| Pulmonary Artery | 1 | 1993 | 1946 | 0.060 |
Why?
|
| Reference Values | 3 | 2024 | 4938 | 0.060 |
Why?
|
| Propafenone | 1 | 2023 | 27 | 0.060 |
Why?
|
| Therapeutic Irrigation | 1 | 2005 | 297 | 0.060 |
Why?
|
| Flecainide | 1 | 2023 | 41 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2002 | 6229 | 0.050 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2007 | 362 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2014 | 2981 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6526 | 0.050 |
Why?
|
| Case-Control Studies | 6 | 2024 | 22291 | 0.050 |
Why?
|
| Dogs | 2 | 2005 | 3845 | 0.050 |
Why?
|
| Cicatrix | 2 | 2001 | 798 | 0.050 |
Why?
|
| Animals | 15 | 2016 | 169246 | 0.050 |
Why?
|
| Video-Assisted Surgery | 1 | 2003 | 51 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8542 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2008 | 2107 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2008 | 741 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 830 | 0.050 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 1110 | 0.050 |
Why?
|
| Aspirin | 1 | 2013 | 3135 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2014 | 9669 | 0.050 |
Why?
|
| Atropine | 3 | 2000 | 244 | 0.050 |
Why?
|
| Ventricular Function | 1 | 2003 | 405 | 0.050 |
Why?
|
| Diagnostic Imaging | 3 | 2021 | 3533 | 0.050 |
Why?
|
| Observer Variation | 2 | 2004 | 2622 | 0.040 |
Why?
|
| Atrial Function | 1 | 2001 | 98 | 0.040 |
Why?
|
| Anaphylaxis | 1 | 2008 | 758 | 0.040 |
Why?
|
| Action Potentials | 2 | 2020 | 1838 | 0.040 |
Why?
|
| Steroids | 1 | 2005 | 938 | 0.040 |
Why?
|
| Catheterization | 1 | 2005 | 1430 | 0.040 |
Why?
|
| Latin America | 1 | 2021 | 416 | 0.040 |
Why?
|
| Propranolol | 3 | 2000 | 493 | 0.040 |
Why?
|
| Postoperative Period | 3 | 1994 | 1826 | 0.040 |
Why?
|
| Statistics, Nonparametric | 3 | 2012 | 2862 | 0.040 |
Why?
|
| Adenosine | 2 | 2013 | 820 | 0.040 |
Why?
|
| Hemodynamics | 5 | 2009 | 4194 | 0.040 |
Why?
|
| Organ Size | 1 | 2024 | 2267 | 0.040 |
Why?
|
| Artifacts | 1 | 2007 | 1926 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 1232 | 0.040 |
Why?
|
| Tricuspid Valve | 2 | 2004 | 419 | 0.040 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2024 | 646 | 0.040 |
Why?
|
| Age of Onset | 2 | 2016 | 3347 | 0.040 |
Why?
|
| Acute Disease | 1 | 2009 | 7243 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2006 | 1162 | 0.040 |
Why?
|
| Software | 3 | 2008 | 4478 | 0.040 |
Why?
|
| Lung Volume Measurements | 2 | 2002 | 381 | 0.040 |
Why?
|
| Radiography | 2 | 2009 | 6983 | 0.040 |
Why?
|
| Europe | 2 | 2014 | 3436 | 0.040 |
Why?
|
| Exercise | 1 | 2014 | 5955 | 0.040 |
Why?
|
| Atrial Function, Right | 1 | 1997 | 32 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2024 | 1091 | 0.030 |
Why?
|
| Length of Stay | 2 | 2020 | 6498 | 0.030 |
Why?
|
| Ecchymosis | 1 | 1997 | 32 | 0.030 |
Why?
|
| Off-Label Use | 1 | 2018 | 185 | 0.030 |
Why?
|
| Patients | 1 | 2023 | 908 | 0.030 |
Why?
|
| Seasons | 1 | 2002 | 1524 | 0.030 |
Why?
|
| Embolism, Air | 1 | 1997 | 110 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2013 | 6004 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2017 | 687 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2006 | 1893 | 0.030 |
Why?
|
| Pressoreceptors | 1 | 1996 | 99 | 0.030 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2018 | 312 | 0.030 |
Why?
|
| Robotics | 1 | 2003 | 812 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2017 | 2230 | 0.030 |
Why?
|
| Linear Models | 2 | 2018 | 5884 | 0.030 |
Why?
|
| Bradycardia | 1 | 1997 | 305 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 13014 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 15948 | 0.030 |
Why?
|
| Heart Arrest, Induced | 1 | 1996 | 359 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2003 | 1776 | 0.030 |
Why?
|
| Advisory Committees | 1 | 2018 | 797 | 0.030 |
Why?
|
| Proportional Hazards Models | 4 | 2014 | 12543 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 1999 | 1741 | 0.030 |
Why?
|
| Reaction Time | 1 | 2000 | 2101 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2020 | 1480 | 0.030 |
Why?
|
| Massachusetts | 2 | 2017 | 8890 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2013 | 41754 | 0.030 |
Why?
|
| Photoplethysmography | 1 | 1994 | 66 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2005 | 12465 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 1994 | 439 | 0.030 |
Why?
|
| Posture | 2 | 1997 | 957 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 3390 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 1997 | 629 | 0.030 |
Why?
|
| Metals | 2 | 2007 | 713 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 97 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2012 | 147 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 18065 | 0.020 |
Why?
|
| Rhabdomyoma | 1 | 2011 | 56 | 0.020 |
Why?
|
| Aortography | 1 | 1993 | 422 | 0.020 |
Why?
|
| Feedback | 1 | 1995 | 799 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4978 | 0.020 |
Why?
|
| Myxoma | 1 | 2011 | 114 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2002 | 2593 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 1406 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 10760 | 0.020 |
Why?
|
| Lung | 2 | 2002 | 10099 | 0.020 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1992 | 216 | 0.020 |
Why?
|
| Temperature | 1 | 1997 | 2234 | 0.020 |
Why?
|
| Vagus Nerve | 1 | 1993 | 459 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 461 | 0.020 |
Why?
|
| Fibroma | 1 | 2011 | 197 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 1993 | 991 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 687 | 0.020 |
Why?
|
| Longitudinal Studies | 3 | 2015 | 14783 | 0.020 |
Why?
|
| Plasma Substitutes | 1 | 1989 | 57 | 0.020 |
Why?
|
| Starch | 1 | 1989 | 81 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2023 | 3288 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 633 | 0.020 |
Why?
|
| Internationality | 1 | 2014 | 1008 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2014 | 846 | 0.020 |
Why?
|
| Dissection | 1 | 2010 | 299 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 1994 | 712 | 0.020 |
Why?
|
| Hospitalization | 2 | 2018 | 10840 | 0.020 |
Why?
|
| Child Welfare | 2 | 2002 | 523 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 2125 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 1993 | 758 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 527 | 0.020 |
Why?
|
| Heart Arrest | 1 | 1997 | 1516 | 0.020 |
Why?
|
| Albumins | 1 | 1989 | 577 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 2011 | 916 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 26379 | 0.020 |
Why?
|
| Pharmacokinetics | 1 | 2005 | 86 | 0.020 |
Why?
|
| Wound Healing | 1 | 1997 | 2809 | 0.020 |
Why?
|
| Aorta | 1 | 1993 | 2045 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2001 | 22379 | 0.020 |
Why?
|
| Phlebography | 1 | 2006 | 326 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3814 | 0.010 |
Why?
|
| Fibrosis | 1 | 2012 | 2080 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2014 | 2258 | 0.010 |
Why?
|
| Acoustics | 1 | 2006 | 244 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2006 | 1162 | 0.010 |
Why?
|
| Connexins | 1 | 2006 | 355 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 687 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2006 | 475 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1985 | 642 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 2004 | 245 | 0.010 |
Why?
|
| Heart Failure | 1 | 2007 | 11879 | 0.010 |
Why?
|
| Prognosis | 4 | 2007 | 30010 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2006 | 1647 | 0.010 |
Why?
|
| Computer Systems | 1 | 2004 | 469 | 0.010 |
Why?
|
| Patient Selection | 1 | 2014 | 4260 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20760 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2017 | 4852 | 0.010 |
Why?
|
| Thoracoscopy | 1 | 2003 | 186 | 0.010 |
Why?
|
| Stroke | 1 | 2004 | 9755 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2013 | 4541 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8748 | 0.010 |
Why?
|
| Cholinergic Agonists | 1 | 2001 | 75 | 0.010 |
Why?
|
| Veins | 1 | 2005 | 769 | 0.010 |
Why?
|
| Random Allocation | 2 | 2000 | 2396 | 0.010 |
Why?
|
| Carbachol | 1 | 2001 | 223 | 0.010 |
Why?
|
| Aortic Valve | 1 | 2010 | 1970 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2014 | 3301 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 2479 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2521 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2001 | 210 | 0.010 |
Why?
|
| Suture Techniques | 1 | 2004 | 775 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2013 | 5349 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2004 | 1097 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 1321 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2002 | 1500 | 0.010 |
Why?
|
| Cell Communication | 1 | 2006 | 1660 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8741 | 0.010 |
Why?
|
| North America | 1 | 2002 | 1289 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2007 | 2512 | 0.010 |
Why?
|
| Databases, Factual | 2 | 2007 | 8080 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2002 | 721 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13671 | 0.010 |
Why?
|
| Cardiotonic Agents | 1 | 2001 | 542 | 0.010 |
Why?
|
| Age Distribution | 1 | 2004 | 2873 | 0.010 |
Why?
|
| Monitoring, Ambulatory | 1 | 2001 | 358 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2004 | 2661 | 0.010 |
Why?
|
| Procainamide | 1 | 1997 | 56 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 1985 | 1351 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7454 | 0.010 |
Why?
|
| Cause of Death | 1 | 2007 | 3721 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6082 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 5520 | 0.010 |
Why?
|
| Neoplasms | 1 | 1985 | 22371 | 0.010 |
Why?
|
| Stochastic Processes | 1 | 1997 | 360 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2004 | 1475 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 2415 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1996 | 272 | 0.010 |
Why?
|
| Phenylephrine | 1 | 1996 | 292 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 1627 | 0.010 |
Why?
|
| Research | 1 | 2003 | 1979 | 0.010 |
Why?
|
| Hydrops Fetalis | 1 | 1994 | 113 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 1377 | 0.010 |
Why?
|
| Aged | 5 | 2011 | 171504 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 3537 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11095 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 1997 | 754 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2003 | 8054 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1997 | 1443 | 0.010 |
Why?
|
| Reoperation | 1 | 2001 | 4329 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 23760 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2000 | 2008 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11669 | 0.000 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 6568 | 0.000 |
Why?
|
| Water-Electrolyte Balance | 1 | 1989 | 326 | 0.000 |
Why?
|
| Models, Biological | 1 | 2002 | 9495 | 0.000 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1994 | 1772 | 0.000 |
Why?
|
| Neural Pathways | 1 | 1996 | 3117 | 0.000 |
Why?
|
| Mice | 2 | 2001 | 82029 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 36743 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1985 | 13676 | 0.000 |
Why?
|
| Phenotype | 1 | 2000 | 16726 | 0.000 |
Why?
|
| Pregnancy | 1 | 1994 | 30256 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 59629 | 0.000 |
Why?
|